DHR · CIK 0000313616 · operating
Danaher Corporation designs, manufactures, and markets professional instruments, consumables, and services across biotechnology, life sciences, and diagnostics. The company serves pharmaceutical manufacturers, research institutions, hospitals, and clinical laboratories through an extensive portfolio of brands including Beckman Coulter, Leica Microsystems, Pall, Phenomenex, and Sciex, among others.
The Biotechnology segment supplies bioprocessing technologies and manufacturing solutions for therapeutic development, including single-use systems, chromatography resins, filtration technologies, and cell culture media. The Life Sciences segment offers analytical instruments such as mass spectrometers, flow cytometers, and genomic analysis tools, alongside consumables for laboratory research and custom nucleic acid products. The Diagnostics segment provides clinical laboratory instruments and reagents for chemistry, immunoassay, hematology, and microbiology testing in hospital and reference laboratory settings.
Danaher operates at significant scale with approximately 60,000 full-time employees and maintains a global footprint spanning the United States, China, and other international markets. The company was founded in 1969 and is headquartered in Washington, DC.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $5.05 | $5.07 | -4.5% | |
| 2024 | $5.29 | $5.33 | +264.8% | |
| 2023 | $1.45 | $1.46 | -85.0% | |
| 2022 | $9.66 | $9.80 | +12.2% | |
| 2021 | $8.61 | $8.77 | +76.1% | |
| 2020 | $4.89 | $4.97 | +182.7% | |
| 2019 | $1.73 | $1.75 | +64.8% | |
| 2018 | $1.05 | $1.06 | -13.2% | |
| 2017 | $1.21 | $1.23 | +13.1% | |
| 2016 | $1.07 | $1.08 | +8.1% | |
| 2015 | $0.99 | $1.00 | +7.6% | |
| 2014 | $0.92 | $0.94 | -17.1% | |
| 2013 | $1.11 | $1.13 | +24.7% | |
| 2012 | $0.89 | $0.91 | +11.2% | |
| 2011 | $0.80 | $0.83 | +15.9% | |
| 2010 | $0.69 | $0.72 | -80.1% | |
| 2009 | $3.46 | $3.59 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-24 | 0000313616-26-000062 | SEC ↗ |
| 2024-12-31 | 2025-02-20 | 0000313616-25-000043 | SEC ↗ |
| 2023-12-31 | 2024-02-21 | 0000313616-24-000052 | SEC ↗ |
| 2022-12-31 | 2023-02-22 | 0000313616-23-000087 | SEC ↗ |
| 2021-12-31 | 2022-02-23 | 0000313616-22-000061 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0000313616-21-000045 | SEC ↗ |
| 2019-12-31 | 2020-02-21 | 0000313616-20-000041 | SEC ↗ |